Monday, June 23, 2014

Tarceva® Forecast Model, only 13 days left to avail inaugural discount of $1000

It gives us immense pleasure to announce the launch of the long term forecasting model for lung cancer drug Tarceva®. BCC Research Tarceva® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters.

Highlights of Tarceva Forecast Model
  • Market demand forecasts for Tarceva® annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
  • Segmentation by volume and value for the following regions: U.S., Japan, Europe, Latin America, China, Asia, and Middle East
  • Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence
Clickhere to view the data sheet of Tarceva® Forecast Model.

How can Tarceva Forecast Model Help You?
  • Examine market demand forecast for Tarceva®: Competitor assessment; Market opportunity assessment
  • Identify new business and investment opportunities for products in the lung cancer segment
  • Validate other Tarceva® market-demand data to which you have access
Click here to download a complimentary sample of the Tarceva®  Forecast Model.
And what’s more? We are offering you an inaugural discount of $1000 on the list price of $5500. Purchase the Tarceva forecast model at a special price of $4500 till June 30th, 2014.

You can also avail our combo offer of
 any BCC Research report + Tarceva Forecast Model for the price of $9500.

To learn more, you can also view our video at

Contact us at (+1) 781-489-7301, ext.1 or write to us at

No comments:

Post a Comment

Bookmark and Share